Partially correct direction but weak execution — META did underperform SPY (META -1.8% vs SPY +0.2%, a -2.0% gap). However, the thesis reasoning appears flawed: TSLA actually outperformed at +3.9%, contradicting the biotech rotation narrative. The prediction was directionally right but for potentially wrong reasons.